MFAP4 Antibody, FITC conjugated
- 
								中文名稱:MFAP4兔多克隆抗體, FITC偶聯(lián)
- 
								貨號(hào):CSB-PA013749LC01HU
- 
								規(guī)格:¥880
- 
								其他:
產(chǎn)品詳情
- 
											產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) MFAP4 Polyclonal antibody
- 
											Uniprot No.:
- 
											基因名:MFAP4
- 
											別名:MFAP4 antibody; MFAP4_HUMAN antibody; Microfibril-associated glycoprotein 4 antibody; Microfibrillar associated protein 4 antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human
- 
											免疫原:Recombinant Human Microfibril-associated glycoprotein 4 protein (100-191AA)
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:FITC
- 
											克隆類型:Polyclonal
- 
											抗體亞型:IgG
- 
											純化方式:>95%, Protein G purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:Preservative: 0.03% Proclin 300
 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
- 
											產(chǎn)品提供形式:Liquid
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
- 
											功能:Could be involved in calcium-dependent cell adhesion or intercellular interactions. May contribute to the elastic fiber assembly and/or maintenance.
- 
											基因功能參考文獻(xiàn):- the applicability of MFAP4 as a novel serum biomarker for assessment of hepatic fibrosis and identification of high-risk patients with severe fibrosis stages in hepatitis C, is reported. PMID: 27378383
- No association between pMFAP4 and macrovascular vascular complications was found. However, high levels of pMFAP4 correlated independently with diabetic neuropathy. PMID: 28039584
- These studies have identified and validated new factors enriched in juvenile chondrocytes as compared to adult chondrocytes including secreted extracellular matrix factors chordin-like 1 (CHRDL1) and microfibrillar-associated protein 4 (MFAP4). PMID: 26955889
- plasma MFAP4 was significantly increased among patients with a previous diagnosis of liver disease or congestive heart failure compared to patients with other diagnoses. PMID: 26460565
- Data suggest that MFAP4 specifically binds tropoelastin and fibrillin-1/-2, as well as elastin cross-linking amino acid desmosine; MFAP4 co-localizes with fibrillin-1-positive fibers; MFAP4 actively promotes tropoelastin self-assembly. PMID: 26601954
- MFAP4 regulates integrin alphaVbeta3-induced VSMC proliferation and migration, as well as monocyte chemotaxis, and accelerates neointimal hyperplasia after vascular injury. PMID: 26564819
- Serum MFAP4 varies in groups of patients with different cardiovascular conditions. PMID: 24349233
- The findings support the biomarker potential of systemic MFAP4, with elevated levels in the serum reflecting pathological processes involving ECM remodeling and degradation. PMID: 24324779
- skin with enhanced MFAP-4 expression was protected from UVB-induced photodamage/photoaging accompanied by the prevention of ECM degradation and aggravated elasticity PMID: 22355679
- Microfibrillar associated protein 4 binds pulmonary surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. PMID: 16867155
 顯示更多 收起更多 
- 
											亞細(xì)胞定位:Secreted, extracellular space, extracellular matrix.
- 
											數(shù)據(jù)庫鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          